insights_auto
Why is GH down 2,04%?
Dive Deeperchevron_right
GH:NASDAQ
Guardant Health Inc
US$151,70
arrow_downward
-2,04%(-3,16) 1D
13 ພ.ຈ., 16 ໂມງ 0 ນາທີ 00 ວິນາທີ GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GH...
Open
US$156,02
High
US$156,02
Low
US$148,01
Mkt. cap
20,52 ຕື້
Avg. vol.
2,13 ລ້ານ
Volume
1,29 ລ້ານ
52-wk high
US$191,01
52-wk low
US$74,55
EPS
US$-3,68
Beta
1,67
Shares outstanding
135,29 ລ້ານ
No. of employees
2 ພັນ
Open
US$156,02
High
US$156,02
Low
US$148,01
Mkt. cap
20,52 ຕື້
Avg. vol.
2,13 ລ້ານ
Volume
1,29 ລ້ານ
52-wk high
US$191,01
52-wk low
US$74,55
EPS
US$-3,68
Beta
1,67
Shares outstanding
135,29 ລ້ານ
No. of employees
2 ພັນ
News stories
From web sources and news partners
Investing.com
·
2 ມື້ກ່ອນ
Guardant Health plans $500 million convertible notes offering
Trefis
·
2 ມື້ກ່ອນ
Could You Have Seen The Run In Guardant Health Stock Coming?
Profile
Guardant Health, Inc. is an American biotechnology company based in Palo Alto, California. Co-founders Helmy Eltoukhy and AmirAli Talasaz serve as co-chief executive officers. Wikipedia
About Guardant Health Inc
CEOHelmy Eltoukhy | AmirAli Talasaz
Employees2,5 ພັນ
Founded2012
HeadquartersPalo Alto, ແຄລິຟໍເນຍ, ສະຫະລັດ
SectorHealth Care
IndustryHealth care provider
Websiteguardanthealth.com